Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

Storm Therapeutics bolsters its team

Professor Mark Dawson and Dr Paul Leeson join its scientific advisory board

- PMLiVE

MSD’s Keytruda wins bladder cancer indication in Japan

Becomes first anti-PD1 approved in the country for previously treated UC

- PMLiVE

FDA’s year-end approvals take annual tally to 46

Rhopressa and Steglatro were among the final medicines licensed last year

- PMLiVE

Mallinckrodt pays $1.2bn for Sucampo Pharma

The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects

- PMLiVE

Delivering real patient value

Three practical steps to achieving a patient-focused comms plan

- PMLiVE

Taming the Monster

Will pharma’s pursuit of marketing effectiveness continue to give it sleepless nights?

- PMLiVE

Astellas promotes Anthony Fiordaliso to VP, Americas finance

He first joined the pharma firm in 2010 from Schering-Plough

Are you providing the kind of content that affiliates want? 5 questions to answer.

To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning core materials.

Anthill Agency

Roche Basel Switzerland

Roche buys cancer company Ignyta for $1.7bn

Pursues same oncology target that encouraged Bayer's recent deal with Loxo

- PMLiVE

Greg Perry joins IFPMA as assistant director general

Will move to the global industry body from the Medicines Patent Pool

- PMLiVE

Adopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

- PMLiVE

Health coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links